Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
iomeprol
- Development stage
- Approved
- Lead developer
- Bracco Diagnostics
- Modality
- Small Molecules
- Administration
- Intra-arterial, Intravenous
01
Overview
Iomeprol is a non-ionic, water-soluble, monomeric iodinated contrast medium (ICM) used in diagnostic radiology. Developed by Bracco, it is classified as a low-osmolar contrast medium (LOCM) and is available in high iodine concentrations (up to 400 mgI/mL). Iomeprol is widely utilized for various imaging procedures, including computed tomography (CT), angiography, and urography, to enhance the visualization of vascular structures and organs. Clinical studies have extensively evaluated its renal safety profile, particularly in high-risk patients with pre-existing chronic kidney disease, often comparing its incidence of contrast-induced nephropathy (CIN) to iso-osmolar agents like iodixanol. It is also employed in specialized applications such as contrast-enhanced mammography (CEM) and pancreatic computed tomography angiography (CTA).
- Brand names
- IomeronImeron
- Other names
- iomeprolIomeprolum
Beyond the preview
Go deeper on iomeprol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on iomeprol.